Description
Denoci 60mg Injection: A Comprehensive Overview
Denoci 60mg Injection contains Denosumab, a human monoclonal antibody. Doctors use this medication to treat bone loss and to prevent significant bone complications in various cancers, such as bone metastases in solid tumors and osteoporosis. As a monoclonal antibody, Denosumab works by a highly specific mechanism. It actively inhibits the Receptor Activator of Nuclear Factor-kappa B Ligand (RANKL). Consequently, blocking RANKL helps regulate bone resorption—the process where specialized cells (osteoclasts) break down bone tissue. By inhibiting these osteoclasts, the drug decreases bone destruction. For this reason, it is a crucial therapy for reducing the risk of fractures and skeletal-related events in oncology patients.
Usage, Administration, and Therapeutic Protocols
A healthcare professional administers this injection subcutaneously, typically once every 4 weeks or every 6 months, depending on the patient’s condition and the specific indication. For instance, the dosage schedule for preventing fractures in osteoporosis is usually less frequent than the schedule used for managing cancer-related bone problems. Furthermore, the drug is used in patients at high risk of fractures or skeletal-related events. Treatment should always be guided by a healthcare provider’s recommendations. The subcutaneous route of administration is preferred for ease and consistent delivery.
Manufacturing, Safety, and Monitoring
Cipla manufactures Denoci 60mg Injection. While it is an essential therapy for bone health, a patient may experience some side effects. Common adverse effects include back pain, pain in the extremities, musculoskeletal pain, and low calcium levels in the blood (hypocalcemia). However, a more serious concern involves the potential for hypocalcemia. For this reason, doctors consider regular monitoring of calcium levels essential throughout the entire course of treatment, especially in the initial weeks. Additionally, doctors also monitor patients for a rare but serious side effect called osteonecrosis of the jaw (ONJ). Therefore, maintaining good oral hygiene is very important during therapy.
Availability & Purchase Information
Genetec Lifesciences makes Denoci 60mg Injection available. To place an order or request a quote, please contact us directly. We ensure that we source all products from verified and authorized vendors.
Disclaimer
This site provides product information for informative purposes only. The product image belongs to its respective company. Genetec Lifesciences acts as a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or its authorized vendors.